(Q51938713)

18 April 2018

title

SkelGen: a general tool for structure-based de novo ligand design. (English)

1 reference

18 April 2018

author

Stewart B. Kirton

4

1 reference

18 April 2018

author name string

Philip M Dean

1

1 reference

18 April 2018

Stuart Firth-Clark

2

1 reference

18 April 2018

William Harris

3

1 reference

18 April 2018

Nikolay P Todorov

5

1 reference

18 April 2018

language of work or name

English

0 references

publication date

1 July 2006

1 reference

18 April 2018

Expert Opinion on Drug Discovery

published in

1 reference

18 April 2018

volume

1

1 reference

18 April 2018

issue

2

1 reference

18 April 2018

page(s)

179-189

1 reference

18 April 2018

Development of a virtual screening method for identification of "frequent hitters" in compound libraries

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Integrating virtual screening in lead discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Pursuing the leadlikeness concept in pharmaceutical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

A fully integrated protein crystallization platform for small-molecule drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Fragment-based lead discovery using X-ray crystallography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Modern computational chemistry and drug discovery: structure generating programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Aspartic protease inhibitors designed from computer-generated templates bind as predicted.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

De novo design of enzyme inhibitors by Monte Carlo ligand generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

A validation study on the practical use of automated de novo design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Detailed analysis of scoring functions for virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

RECAP--retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Efficient evaluation of binding free energy using continuum electrostatics solvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Receptor flexibility in de novo ligand design and docking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Extending the accuracy limits of prediction for side-chain conformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Fragment-Based Drug Discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Exhaustive de novo design of low-molecular-weight fragments against the ATP-binding site of DNA-gyrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

DNA gyrase: structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

A fast flexible docking method using an incremental construction algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Flexible ligand docking using conformational ensembles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

DREAM++: flexible docking program for virtual combinatorial libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Fragment-Based flexible ligand docking by evolutionary optimization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Structure-based ligand design for flexible proteins: application of new F-DycoBlock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Molecular basis of agonism and antagonism in the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Grand canonical Monte Carlo simulation of ligand-protein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Structure-based drug design: computational advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Discovery of cell-permeable non-peptide inhibitors of beta-secretase by high-throughput docking and continuum electrostatics calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Can we rationally design promiscuous drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Transporters and drug discovery: why, when, and how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Computer-aided design of small molecules for chemical genomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening Application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

Rational modification of human synovial fluid phospholipase A2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.1.2.179

21 January 2018

Identifiers

DOI

10.1517/17460441.1.2.179

1 reference

18 April 2018

1 reference

18 April 2018